Second chance: drug combo retested for tough colorectal cancer
Disease control
Not yet recruiting
This study tests whether giving a combination of two drugs (encorafenib and cetuximab) again can help people with a specific genetic type of advanced colorectal cancer (BRAF V600E mutation) who have already tried similar treatments. About 25 adults will receive the drugs until th…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated May 17, 2026 02:45 UTC